Angelica AcutilobaRoot Alleviates Advanced Glycation End-Product-Mediated Renal Injury in Streptozotocin-Diabetic Rats

Journal of Food Science

Volumn 76, Issue 7, 2011, Pages

  Liu, I Min ^a   Tzeng, Thing Fong ^b   Liou, Shorong Shii ^a   Chang, Chia Ju ^c  

^a TAJEN UNIVERSITY   (Taiwan)

^b Pao Chien Hospital   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Advanced glycation end products; Angelica acutilobaroot; Diabetic nephropathy; Streptozotocin diabetic rats

Indexed keywords

ANGELICA SINENSIS; RATTUS;

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; ANTIDIABETIC AGENT; FLAVONOID; IMMUNOGLOBULIN RECEPTOR; LIPID; PLANT EXTRACT; POLYPHENOL;

ANGELICA; ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DIABETIC NEPHROPATHY; EXPERIMENTAL DIABETES MELLITUS; GLOMERULUS; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; METABOLISM; PATHOLOGY; PLANT ROOT; RAT; TAIWAN; WISTAR RAT;

ANGELICA; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FLAVONOIDS; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY GLOMERULUS; LIPIDS; MALE; PLANT EXTRACTS; PLANT ROOTS; POLYPHENOLS; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; TAIWAN;

EID: 84860391839     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/j.1750-3841.2011.02310.x     Document Type: Article

References (30)

1. Bakris GL. 2004. The importance of blood pressure control in the patient with diabetes. Am J Chin Med 116:S30-8.
2. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. 1990. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 346:371-4.
3. Chappey O, Dosquet C, Wautier MP, Wautier JL. 1997. Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest 27:97-108.
4. Falk RJ, Scheinman JI, Mauer SM, Michael AF. 1983. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 32:34-9.
5. Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. 1996. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271:9982-6.
6. Gross ML, Heiss N, Weckbach M, Hansen A, El-Shakmak A, Szabo A, Münter K, Ritz E, Amann K. 2003. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia 46:856-68.
7. Hodge HC, Downs WL, Panner BS, Smith DW, Maynard EA. 1967. Oral toxicity and metabolism of diuron (N-(3, 4-dichlorophenyl)-N', N'-dimethylurea) in rats and dogs. Food Chem Toxicol 5:513-31.
8. Huntley AL, Ernst E. 2003. A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause 10:465-76.
9. Janero DR, Burghardt B. 1988. Analysis of cardiac membrane phospholipid peroxidation kinetics as malondialdehyde: nonspecificity of thiobarbituric acid-reactivity. Lipids 23:452-8.
10. Janiak P, Bidouard JP, Cadrouvele C, Poirier B, Gouraud L, Grataloup Y, Pierre F, Bruneval P, O'Connor SE, Herbert JM. 2006. Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats. Eur J Pharmacol 534:271-9.
11. Jung K, Pergande M. 1985. Influence of cyclosporin A on the respiration of isolated rat kidney mitochondria. FEBS Lett 183:167-9.
12. Kalantarinia K, Okusa MD. 2006. The renin-angiotensin system and its blockade in diabetic renal and cardiovascular disease. Curr Diab Rep 6:8-16.
13. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR. 2008. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med 233:4-11.
14. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M. 2003. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 14:S250-3.
15. Liu IM, Tzeng TF, Liou SS, Chang CJ. 2011. Angelica acutiloba root attenuates insulin resistance induced by high-fructose diet in rats. Phytother Res. DOI: 10.1002/ptr.3403.
16. Lu GH, Chan K, Liang YZ, Leung K, Chan CL, Jiang ZH, Zhao ZZ. 2005. Development of high-performance liquid chromatographic fingerprints for distinguishing Chinese Angelica from related umbelliferae herbs. J Chromatogr A 1073:383-92.
17. Nakayama H, Mitsuhashi T, Kuwajima S, Aoki S, Kuroda Y, Itoh T, Nakagawa S. 1993. Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat. Diabetes 42:345-50.
18. Nishikawa T, Araki E. 2007. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 9:343-53.
19. Piao XL, Park JH, Cui J, Kim DH, Yoo HH. 2007. Development of gas chromatographic/mass spectrometry-pattern recognition method for the quality control of Korean Angelica. J Pharm Biomed Anal 44:1163-7.
20. Prabhakar S, Starnes J, Shi S, Lonis B, Tran R. 2007. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J Am Soc Nephrol 18:2945-52.
21. Sarker SD, Nahar L. 2004. Natural medicine: the genus Angelica. Curr Med Chem 11:1479-1500.
22. Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L. 2005. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287-306.
23. Schrijvers BF, Vriese AS. 2007. Novel insights in the treatment of diabetic nephropathy. Acta Clin Belg 62:278-90.
24. Siu B, Saha J, Smoyer WE, Sullivan KA, Brosius FC 3rd. 2006. Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC Nephrol 7:6-16.
25. [TDCCTRG] The Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-86.
26. Vasavada N, Agarwal R. 2005. Role of oxidative stress in diabetic nephropathy. Adv Chronic Kidney Dis 12:146-54.
27. Viberti G, Wheeldon NM. 2002. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect. Circulation 106:672-8.
28. Wing RR, Goldstein MG, Acton KJ, Birch LL, Jakicic JM, Sallis JF Jr, Smith-West D, Jeffery RW, Surwit RS. 2001. Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care 24:117-23.
29. Yamagishi S, Fukami K, Ueda S, Okuda S. 2007. Molecular mechanisms of diabetic nephropathy and its therapeutic intervention. Curr Drug Targets 8:952-9.
30. Zhao KJ, Dong TT, Tu PF, Song ZH, Lo CK, Tsim KW. 2003. Molecular genetic and chemical assessment of radix Angelica (Danggui) in China. J Agric Food Chem 51:2576-83.